Answers are grounded in this paper and cite their sources.
Background/Objectives: Childhood-onset epilepsies that do not remit are the patients adult neurologists inherit at transition, yet no framework predicts adult neurological status or mortality from pediatric features. We reviewed the longitudinal evidence. Methods: PubMed/MEDLINE, Embase, Scopus and the Cochrane Library were searched from 1980 to 5 November 2026 for cohort or population-based studies of epilepsy with onset before 18 years; studies contributing to the synthesis of long-term outcomes required five or more years of follow-up. Risk of bias was rated with the Quality In Prognosis Studies (QUIPS) tool. The cohorts differed in the definition of remission, in the age at outcome ascertainment and in the quantities reported, and several publications describe the same underlying cohorts, so the evidence is presented as a structured narrative synthesis without pooled estimates, following PRISMA 2020. Results: Fourteen studies were included. They report on 4326 participants with epilepsy, which is the sum of the sample sizes of the individual publications and not a count of distinct individuals, because three groups of publications report on the same underlying cohorts; follow-up ranged from 2 to 50 years. Reported seizure freedom ranged from 90% of 195 patients with no seizures at final follow-up to 93% of 47 children with absence epilepsy, each cohort using its own definition, and 62% of the 421 patients in the Nova Scotia cohort reached terminal remission. A Danish tertiary cohort reported 8 SUDEP cases per 10,000 patient-years, and more than 95% of the patients who died there had drug-resistant epilepsy. In the Dutch cohort the standardized mortality ratio was 22.9 (95% CI 7.9 to 37.9) for symptomatic epilepsy, with no deaths among 328 children with non-symptomatic epilepsy. Drug resistance was associated with a full-scale IQ 11.4 points lower in the Connecticut cohort, measured eight to nine years after onset. Conclusions: Drug resistance, symptomatic etiology and early seizure onset recur across cohorts as markers of less favorable adult outcome and support prognostic risk stratification at the transition to adult care rather than individual prediction. The evidence is observational, heterogeneous in definition and ascertainment, and describes groups rather than individuals.
No takes yet. Share an insight, caveat, or question.
Tecar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: